High-dose dexamethasone (Dex) protects against the hepatotoxicity of ET-743 in the female rat
2002-01-01 Donald, S; Verschoyle, R; Gant, T; Colombo, T; Frapolli, R; D'Incalci, M; Lopez-Lazaro, L; Greaves, P; Gescher, A
E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models
2011-01-01 Bello, E; Colella, G; Scarlato, V; Oliva, P; Berndt, A; Valbusa, G; Serra, Sc; D'Incalci, M; Cavalletti, E; Giavazzi, R; Damia, G; Camboni, G
High-performance liquid chromatographic assay for the determination of Aloe Emodin in mouse plasma
2003-01-01 Zaffaroni, M; Mucignat, C; Pecere, T; Zagotto, G; Frapolli, R; D'Incalci, M; Zucchetti, M
GEMCITABINE (G) AT FIXED DOSE RATE (FDR) INFUSION, COMBINED WITH CISPLATIN (C), IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC). A PHASE II STUDY WITH INCREMENTAL G DOSES
2004-01-01 Caffo, O; Santo, A; Binato, S; Zucchetti, M; Centonze, M; Lucenti, A; Giovannini, M; D'Incalci, M; Cartei, G; Cetto, G; Galligioni, E
ISOLATED BILATERAL ANTERIOR-CHAMBER EYE RELAPSE IN A CHILD WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - DISCUSSION
1995-01-01 Jankovic, M; Conter, V; Pretto, G; Placa, F; D'Incalci, M; Masera, G
Antitumor activity and pharmacokinetics of oral gimatecan on pediatric cancer xenografts
2010-01-01 Zucchetti, M; Meco, D; Di Francesco, Am; Servidei, T; Patriarca, V; Cusano, G; D'Incalci, M; Forestieri, D; Pisano, C; Riccardi, R
Development of novel cancer chemopreventive agents in Europe - Neglected Cinderella or rising phoenix? ESF Workshop on Cancer Chemoprevention, DKFZ, Heidelberg, September 18-20, 2005
2006-01-01 Gerhauser, C; Bartsch, H; Crowell, J; De Flora, S; D'Incalci, M; Dittrich, C; Frank, N; Mihich, E; Steffen, C; Tortora, G; Gescher, A
Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer
2018-01-01 Germano, G; Mauri, G; Siravegna, G; Dive, C; Pierce, J; Di Nicolantonio, F; D'Incalci, M; Bardelli, A; Siena, S; Sartore-Bianchi, A
Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells
2011-01-01 Lovejoy, K. S.; Serova, M.; Bieche, I.; Emami, S.; D'Incalci, M; Broggini, M.; Erba, E.; Gespach, C.; Cvitkovic, E.; Faivre, S.; Raymond, E.; Lippard, S. J.
PTX-008, a dual inhibitor of angiogenesis and tumor cell proliferation, potentiates the antineoplastic activity of targeted therapies in human tumor models
2011-01-01 Bonezzi, K; Frapolli, R; Sala, F; Astorgues-Xerri, L; Serova, M; Raymond, E; Cvitkovic, E; Noel, K; Ubezio, P; Zucchetti, M; D'Incalci, M; Giayazzi, R; Taraboletti, G
Hematopoietic toxicity and cell cycle perturbations induced by new DNA minor groove-alkylating agents
1997-01-01 Filippini, C; Bisiach, M; Tagliabue, G; D'Incalci, M; Ubezio, P
DISTAMYCIN-A AND TALLIMUSTINE INHIBIT TBP BINDING AND BASAL IN-VITRO TRANSCRIPTION
1995-01-01 Bellorini, M; Moncollin, V; D'Incalci, M; Mongelli, N; Mantovani, R
Induction of resistance to Aplidin (R) in a human ovarian cancer cell line related to MDR expression
2005-01-01 Tognon, G; Bernasconi, S; Celli, N; Faircloth, Gt; Cuevas, C; Jimeno, J; Erba, E; D'Incalci, M
SIMPLE AND SENSITIVE METHOD FOR DETERMINATION OF CYCLOPHOSPHAMIDE BY MEANS OF A NITROGEN-PHOSPHORUS SELECTIVE DETECTOR
1978-01-01 Facchinetti, T; D'Incalci, M; Martelli, G; Cantoni, L; Belvedere, G; Salmona, M
MicroRNA PROFILING AS PREDICTIVE FACTOR OF COMPLETE PATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER
2011-01-01 Della Vittoria, Sg; De Stefano, A; Falcetta, F; Carlomagno, C; Ubezio, P; Marchini, S; D'Incalci, M; De Placido, S; Pepe, S
The G-quadruplex ligand RHPS4 inhibits in vivo tumor growth by inducing telomere dysfunction-associated apoptosis
2005-01-01 Leonetti, C; Scarsella, M; Salvati, E; Mottolese, M; Stevens, Mf; D'Incalci, M; Zupi, G; Biroccio, A
Taxoids in combination with anthracyclines and other agents: Pharmacokinetic considerations
1998-01-01 D'Incalci, M; Schuller, J; Colombo, T; Zucchetti, M; Riva, A
Corrections to "Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors"
2015-01-01 Soria, Jc; Debraud, F; Bahleda, R; Adamo, B; Andre, F; Dienstmann, R; Delmonte, A; Cereda, R; Isaacson, J; Litten, J; Allen, A; Dubois, F; Saba, C; Robert, R; D'Incalci, M; Zucchetti, M; Camboni, Mg; Tabernero, J
Striking activity of E-3810 combined with paclitaxel and 5FU in the triple negative breast cancer model MDA-MB-231
2011-01-01 Damia, G; Bello, E; Colella, G; Berndt, A; D'Incalci, M; Cavalletti, E; Camboni, G
Structural characterization of mono- and dihydroxylated metabolites of paclitaxel in rat bile using liquid chromatography ion spray tandem mass spectrometry
1997-01-01 Sottani, C; Minoia, C; Colombo, A; Zucchetti, M; D'Incalci, M; Fanelli, R
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| High-dose dexamethasone (Dex) protects against the hepatotoxicity of ET-743 in the female rat | 1-gen-2002 | Donald, S; Verschoyle, R; Gant, T; Colombo, T; Frapolli, R; D'Incalci, M; Lopez-Lazaro, L; Greaves, P; Gescher, A | |
| E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models | 1-gen-2011 | Bello, E; Colella, G; Scarlato, V; Oliva, P; Berndt, A; Valbusa, G; Serra, Sc; D'Incalci, M; Cavalletti, E; Giavazzi, R; Damia, G; Camboni, G | |
| High-performance liquid chromatographic assay for the determination of Aloe Emodin in mouse plasma | 1-gen-2003 | Zaffaroni, M; Mucignat, C; Pecere, T; Zagotto, G; Frapolli, R; D'Incalci, M; Zucchetti, M | |
| GEMCITABINE (G) AT FIXED DOSE RATE (FDR) INFUSION, COMBINED WITH CISPLATIN (C), IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC). A PHASE II STUDY WITH INCREMENTAL G DOSES | 1-gen-2004 | Caffo, O; Santo, A; Binato, S; Zucchetti, M; Centonze, M; Lucenti, A; Giovannini, M; D'Incalci, M; Cartei, G; Cetto, G; Galligioni, E | |
| ISOLATED BILATERAL ANTERIOR-CHAMBER EYE RELAPSE IN A CHILD WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - DISCUSSION | 1-gen-1995 | Jankovic, M; Conter, V; Pretto, G; Placa, F; D'Incalci, M; Masera, G | |
| Antitumor activity and pharmacokinetics of oral gimatecan on pediatric cancer xenografts | 1-gen-2010 | Zucchetti, M; Meco, D; Di Francesco, Am; Servidei, T; Patriarca, V; Cusano, G; D'Incalci, M; Forestieri, D; Pisano, C; Riccardi, R | |
| Development of novel cancer chemopreventive agents in Europe - Neglected Cinderella or rising phoenix? ESF Workshop on Cancer Chemoprevention, DKFZ, Heidelberg, September 18-20, 2005 | 1-gen-2006 | Gerhauser, C; Bartsch, H; Crowell, J; De Flora, S; D'Incalci, M; Dittrich, C; Frank, N; Mihich, E; Steffen, C; Tortora, G; Gescher, A | |
| Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer | 1-gen-2018 | Germano, G; Mauri, G; Siravegna, G; Dive, C; Pierce, J; Di Nicolantonio, F; D'Incalci, M; Bardelli, A; Siena, S; Sartore-Bianchi, A | |
| Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells | 1-gen-2011 | Lovejoy, K. S.; Serova, M.; Bieche, I.; Emami, S.; D'Incalci, M; Broggini, M.; Erba, E.; Gespach, C.; Cvitkovic, E.; Faivre, S.; Raymond, E.; Lippard, S. J. | |
| PTX-008, a dual inhibitor of angiogenesis and tumor cell proliferation, potentiates the antineoplastic activity of targeted therapies in human tumor models | 1-gen-2011 | Bonezzi, K; Frapolli, R; Sala, F; Astorgues-Xerri, L; Serova, M; Raymond, E; Cvitkovic, E; Noel, K; Ubezio, P; Zucchetti, M; D'Incalci, M; Giayazzi, R; Taraboletti, G | |
| Hematopoietic toxicity and cell cycle perturbations induced by new DNA minor groove-alkylating agents | 1-gen-1997 | Filippini, C; Bisiach, M; Tagliabue, G; D'Incalci, M; Ubezio, P | |
| DISTAMYCIN-A AND TALLIMUSTINE INHIBIT TBP BINDING AND BASAL IN-VITRO TRANSCRIPTION | 1-gen-1995 | Bellorini, M; Moncollin, V; D'Incalci, M; Mongelli, N; Mantovani, R | |
| Induction of resistance to Aplidin (R) in a human ovarian cancer cell line related to MDR expression | 1-gen-2005 | Tognon, G; Bernasconi, S; Celli, N; Faircloth, Gt; Cuevas, C; Jimeno, J; Erba, E; D'Incalci, M | |
| SIMPLE AND SENSITIVE METHOD FOR DETERMINATION OF CYCLOPHOSPHAMIDE BY MEANS OF A NITROGEN-PHOSPHORUS SELECTIVE DETECTOR | 1-gen-1978 | Facchinetti, T; D'Incalci, M; Martelli, G; Cantoni, L; Belvedere, G; Salmona, M | |
| MicroRNA PROFILING AS PREDICTIVE FACTOR OF COMPLETE PATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER | 1-gen-2011 | Della Vittoria, Sg; De Stefano, A; Falcetta, F; Carlomagno, C; Ubezio, P; Marchini, S; D'Incalci, M; De Placido, S; Pepe, S | |
| The G-quadruplex ligand RHPS4 inhibits in vivo tumor growth by inducing telomere dysfunction-associated apoptosis | 1-gen-2005 | Leonetti, C; Scarsella, M; Salvati, E; Mottolese, M; Stevens, Mf; D'Incalci, M; Zupi, G; Biroccio, A | |
| Taxoids in combination with anthracyclines and other agents: Pharmacokinetic considerations | 1-gen-1998 | D'Incalci, M; Schuller, J; Colombo, T; Zucchetti, M; Riva, A | |
| Corrections to "Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors" | 1-gen-2015 | Soria, Jc; Debraud, F; Bahleda, R; Adamo, B; Andre, F; Dienstmann, R; Delmonte, A; Cereda, R; Isaacson, J; Litten, J; Allen, A; Dubois, F; Saba, C; Robert, R; D'Incalci, M; Zucchetti, M; Camboni, Mg; Tabernero, J | |
| Striking activity of E-3810 combined with paclitaxel and 5FU in the triple negative breast cancer model MDA-MB-231 | 1-gen-2011 | Damia, G; Bello, E; Colella, G; Berndt, A; D'Incalci, M; Cavalletti, E; Camboni, G | |
| Structural characterization of mono- and dihydroxylated metabolites of paclitaxel in rat bile using liquid chromatography ion spray tandem mass spectrometry | 1-gen-1997 | Sottani, C; Minoia, C; Colombo, A; Zucchetti, M; D'Incalci, M; Fanelli, R |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891